|Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study|
JW Yaxley, GD Coughlin, SK Chambers, S Occhipinti, H Samaratunga, ...
The Lancet 388 (10049), 1057-1066, 2016
|Use of individual fraction size data from 3756 patients to directly determine the α/β ratio of prostate cancer|
SG Williams, JMG Taylor, N Liu, Y Tra, GM Duchesne, LL Kestin, ...
International Journal of Radiation Oncology* Biology* Physics 68 (1), 24-33, 2007
|[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study|
MS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ...
The Lancet Oncology 19 (6), 825-833, 2018
|Urethral stricture following high dose rate brachytherapy for prostate cancer|
L Sullivan, SG Williams, KH Tai, F Foroudi, L Cleeve, GM Duchesne
Radiotherapy and Oncology 91 (2), 232-236, 2009
|A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk …|
HM Sandler, C Hu, SA Rosenthal, O Sartor, LG Gomella, M Amin, J Purdy, ...
Journal of Clinical Oncology 33 (18), 2015
|Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer|
W Xie, MM Regan, M Buyse, S Halabi, PW Kantoff, O Sartor, H Soule, ...
Journal of Clinical Oncology 35 (27), 3097-3104, 2017
|Online adaptive radiotherapy for muscle-invasive bladder cancer: results of a pilot study|
F Foroudi, J Wong, T Kron, A Rolfo, A Haworth, P Roxby, J Thomas, ...
International Journal of Radiation Oncology* Biology* Physics 81 (3), 765-771, 2011
|High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a phase II trial|
M Barkati, SG Williams, F Foroudi, KH Tai, S Chander, S van Dyk, A See, ...
International Journal of Radiation Oncology* Biology* Physics 82 (5), 1889-1896, 2012
|Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics|
C Proust-Lima, JMG Taylor, S Sécher, H Sandler, L Kestin, T Pickles, ...
International Journal of Radiation Oncology* Biology* Physics 79 (1), 195-201, 2011
|Soy and soy isoflavones in prostate cancer: a systematic review and meta‐analysis of randomized controlled trials|
MD Die, KM Bone, SG Williams, MV Pirotta
BJU international 113 (5b), E119-E130, 2014
|A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy–Adjuvant Versus Early …|
M Pearse, C Fraser‐Browne, ID Davis, GM Duchesne, R Fisher, ...
BJU international 113 (S2), 7-12, 2014
|Real‐time individual predictions of prostate cancer recurrence using joint models|
JMG Taylor, Y Park, DP Ankerst, C Proust‐Lima, S Williams, L Kestin, ...
Biometrics 69 (1), 206-213, 2013
|Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer|
R Khor, G Duchesne, KH Tai, F Foroudi, S Chander, S Van Dyk, M Garth, ...
International Journal of Radiation Oncology* Biology* Physics 85 (3), 679-685, 2013
|Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy|
S Gill, J Thomas, C Fox, T Kron, A Rolfo, M Leahy, S Chander, S Williams, ...
Radiation Oncology 6 (1), 145, 2011
|Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results|
GM Duchesne, SG Williams, R Das, KH Tai
Radiotherapy and Oncology 84 (2), 128-134, 2007
|Pilot comparison of 18F‐fluorocholine and 18F‐fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer|
JM Beauregard, SG Williams, TR DeGrado, P Roselt, RJ Hicks
Journal of medical imaging and radiation oncology 54 (4), 325-332, 2010
|Validating the interval to biochemical failure for the identification of potentially lethal prostate cancer|
MK Buyyounouski, T Pickles, LL Kestin, R Allison, SG Williams
Journal of Clinical Oncology 30 (15), 1857-1863, 2012
|Prostate cancer–specific PET radiotracers: A review on the clinical utility in recurrent disease|
JD Evans, KR Jethwa, P Ost, S Williams, ED Kwon, VJ Lowe, BJ Davis
Practical radiation oncology 8 (1), 28-39, 2018
|Factors predicting for urinary morbidity following 125 iodine transperineal prostate brachytherapy|
SG Williams, JL Millar, GM Duchesne, MJ Dally, PL Royce, RM Snow
Radiotherapy and oncology 73 (1), 33-38, 2004
|Health-related quality of life, psychological distress, and sexual changes following prostate cancer: a comparison of gay and bisexual men with heterosexual men|
JM Ussher, J Perz, A Kellett, S Chambers, D Latini, ID Davis, D Rose, ...
The journal of sexual medicine 13 (3), 425-434, 2016